Serving hundreds of leading biopharmaceutical companies globally:

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 7,399,632

Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,399,632

Title:	Mesenchymal precursor cell
Abstract:	A method of enriching mesenchymal precursor sells including the step of enriching for cells based on at least two markers. The markers may be either i) the presence of markers specific for mesenchymal precursor cells, ii) the absence of markers specific for differentiated mesenchymal cells, or iii) expression levels of markers specific for mesenchymal precursor cells. The method may include a first solid phase sorting step utilizing MACS recognizing expression of the antigen to the STRO-1 Mab, followed by a second sorting step utilizing two color FACS to screen for the presence of high level STRO-1 antigen expression as well as the expression of VCAM-1.
Inventor(s):	Simmons; Paul (East Melbourne, AU), Zannettino; Andrew (Adelaide, AU), Gronthos; Stan (Bethesda, MD)
Assignee:	Angioblast Systems, Incorporated (New York, NY)
Application Number:	11/178,920
Patent Claims:	see list of patent claims

Details for Patent 7,399,632

Subscribe to access the full database, or request a copy of the full page.
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	001	2015-01-23	➤ Sign Up	Angioblast Systems, Incorporated (New York, NY)	2019-07-07	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	002	2015-01-23	➤ Sign Up	Angioblast Systems, Incorporated (New York, NY)	2019-07-07	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	003	2015-01-23	➤ Sign Up	Angioblast Systems, Incorporated (New York, NY)	2019-07-07	RX	Orphan	search
Nps Pharms Inc	NATPARA	parathyroid hormone	INJECTABLE;INJECTION	125511	004	2015-01-23	➤ Sign Up	Angioblast Systems, Incorporated (New York, NY)	2019-07-07	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 7,399,632

Subscribe to access the full database, or request a copy of the full page.
Country	Patent Number	Publication Date
Australia	2004223798	Jun 15, 2006
Australia	2004223798	Oct 07, 2004
Australia	2004224830	Jun 29, 2006
Australia	2004224830	Oct 07, 2004
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.